CLCN1 and Thomsen and Becker disease: Since myotonia congenita-associated mutations may involve enhanced protein degradation and reduced surface expression, it is of high therapeutic significance to decipher the signaling mechanisms as well as the protein machinery essential for CLC-1 biosynthesis.